THE WHAT? L’Oréal USA has reached a confidential settlement with four women who alleged that prolonged use of chemical hair relaxers caused them to develop cancer, resolving the first cases to reach trial amid thousands of similar lawsuits against cosmetics manufacturers in the United States.
THE DETAILS L’Oréal USA and several other hair care manufacturers reached a settlement during proceedings in Cook County, Illinois, where four women had brought claims alleging that chemical hair straightening products contributed to their diagnoses of gynaecological cancers. The trial began on 9 November 2026, with the cases settled for an undisclosed amount. The litigation involves products marketed under brands including Dark & Lovely and Optimum, which have historically targeted consumers with textured hair. More than 12,700 related cases are currently consolidated before a federal judge in Chicago. The lawsuits followed a 2022 National Institutes of Health study identifying an association between frequent chemical hair straightener use and an increased risk of uterine cancer. L’Oréal maintains that its products comply with applicable regulations and undergo rigorous safety assessments, disputing claims that the research establishes a causal relationship. The company also faces separate lawsuits filed by Arizona and Minnesota over allegations concerning product safety disclosures.
THE WHY? The settlement represents a significant development in ongoing product liability litigation affecting the US hair care industry, although it does not establish liability or resolve the thousands of outstanding claims. For cosmetics manufacturers, the proceedings highlight increasing legal and financial exposure associated with ingredient safety, product testing, regulatory compliance and historical marketing practices. The outcome could also influence how companies assess litigation risks and manage their hair care portfolios.
Source: Reuters
